The medical experts of Karachi’s Dow University of Health Sciences (DUHS) on Monday claimed that they have created Intravenous Immunoglobulin (IVIG) – a drug that according to them can treat the infected patients of the fatal coronavirus.
The university administration released a press statement, wherein DUHS Vice Chancellor Muhammad Saeed Quraishy termed the recent development as important breakthrough in the war against Covid-19.
"This way of treatment is safe, low risk and highly effective against coronavirus. Through this method, Immunoglobulin is prepared after separation of antibodies found in the blood of a recovered patient," the statement said, adding that US Food and Drug Administration had earlier approved this form of treatment for coronavirus affectees.
The statement noted that the research team, led by Dr Shaukat Ali, developed this form of treatment after collecting the first blood sample from a recovered coronavirus patient in March. "The team managed to isolate antibodies from the blood sample chemically, purified it and later concentrated these antibodies using ultra-filtration techniques that remove the remaining unwanted materials from the final product," the statement added.
Last week, DUHS’s medical researchers had discovered that certain variants of a human gene may offer resistance against the novel coronavirus, also known as SARS-CoV-2. Their research was later published in the Journal of Medical Virology.
The university administration released a press statement, wherein DUHS Vice Chancellor Muhammad Saeed Quraishy termed the recent development as important breakthrough in the war against Covid-19.
"This way of treatment is safe, low risk and highly effective against coronavirus. Through this method, Immunoglobulin is prepared after separation of antibodies found in the blood of a recovered patient," the statement said, adding that US Food and Drug Administration had earlier approved this form of treatment for coronavirus affectees.
The statement noted that the research team, led by Dr Shaukat Ali, developed this form of treatment after collecting the first blood sample from a recovered coronavirus patient in March. "The team managed to isolate antibodies from the blood sample chemically, purified it and later concentrated these antibodies using ultra-filtration techniques that remove the remaining unwanted materials from the final product," the statement added.
Last week, DUHS’s medical researchers had discovered that certain variants of a human gene may offer resistance against the novel coronavirus, also known as SARS-CoV-2. Their research was later published in the Journal of Medical Virology.